Correlation Between MediciNova and Acrivon Therapeutics,
Can any of the company-specific risk be diversified away by investing in both MediciNova and Acrivon Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MediciNova and Acrivon Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MediciNova and Acrivon Therapeutics, Common, you can compare the effects of market volatilities on MediciNova and Acrivon Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MediciNova with a short position of Acrivon Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of MediciNova and Acrivon Therapeutics,.
Diversification Opportunities for MediciNova and Acrivon Therapeutics,
-0.18 | Correlation Coefficient |
Good diversification
The 3 months correlation between MediciNova and Acrivon is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding MediciNova and Acrivon Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acrivon Therapeutics, and MediciNova is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MediciNova are associated (or correlated) with Acrivon Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acrivon Therapeutics, has no effect on the direction of MediciNova i.e., MediciNova and Acrivon Therapeutics, go up and down completely randomly.
Pair Corralation between MediciNova and Acrivon Therapeutics,
Given the investment horizon of 90 days MediciNova is expected to generate 1.66 times less return on investment than Acrivon Therapeutics,. But when comparing it to its historical volatility, MediciNova is 1.39 times less risky than Acrivon Therapeutics,. It trades about 0.05 of its potential returns per unit of risk. Acrivon Therapeutics, Common is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 365.00 in Acrivon Therapeutics, Common on November 3, 2024 and sell it today you would earn a total of 242.00 from holding Acrivon Therapeutics, Common or generate 66.3% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
MediciNova vs. Acrivon Therapeutics, Common
Performance |
| Timeline |
| MediciNova |
| Acrivon Therapeutics, |
MediciNova and Acrivon Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with MediciNova and Acrivon Therapeutics,
The main advantage of trading using opposite MediciNova and Acrivon Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MediciNova position performs unexpectedly, Acrivon Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acrivon Therapeutics, will offset losses from the drop in Acrivon Therapeutics,'s long position.| MediciNova vs. Aerovate Therapeutics | MediciNova vs. Adagene | MediciNova vs. Acrivon Therapeutics, Common | MediciNova vs. Rezolute |
| Acrivon Therapeutics, vs. Aerovate Therapeutics | Acrivon Therapeutics, vs. Adagene | Acrivon Therapeutics, vs. Rezolute | Acrivon Therapeutics, vs. AN2 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |